Reunion Neuroscience Files Lawsuit Against Mindset Pharma Post published:March 13, 2023 Post category:Press Release
Reunion Neuroscience to Participate in the Oppenheimer Annual Healthcare Conference Post published:March 7, 2023 Post category:Press Release
Reunion Neuroscience Provides Business Update and Reports Fiscal Third Quarter 2023 Financial Results Post published:February 14, 2023 Post category:Press Release
Reunion Neuroscience Schedules Fiscal Third Quarter 2023 Conference Call for Tuesday, February 14, 2023, at 8:30 A.M. ET Post published:February 2, 2023 Post category:Press Release
Reunion Neuroscience Appoints Robert Alexander as Chief Medical Officer Post published:January 23, 2023 Post category:Press Release
Reunion Neuroscience Inc. Provides 2023 Corporate Update Post published:January 6, 2023 Post category:Press Release
Reunion Neuroscience Inc. to Participate in Upcoming Investor Conferences in December Post published:December 6, 2022 Post category:Press Release
Reunion Neuroscience Schedules Fiscal Second Quarter 2023 Conference Call for Monday, November 14, 2022, at 8:30 A.M. ET Post published:November 7, 2022 Post category:Press Release
Reunion Neuroscience to Present at Upcoming November Conferences Post published:November 1, 2022 Post category:Press Release
Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs Post published:October 24, 2022 Post category:Press Release